IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab

Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis

(2022) Zhiwei He et al.   CANCER LETTERS

Blockade of IL-6 inhibits tumor immune evasion and improves anti–PD-1 immunotherapy

(2022) Wenyi Li et al.   CYTOKINE

Value of Cytokine Expression in Early Diagnosis and Prognosis of Tumor Metastasis

(2022) Tingwei Li et al.   Journal of Oncology

Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition

(2020) Andressa S Laino et al.   Journal for ImmunoTherapy of Cancer

Interactions between interleukin-6 and myeloid-derived suppressor cells drive the chemoresistant phenotype of hepatocellular cancer

(2017) Min Xu et al.   EXPERIMENTAL CELL RESEARCH

Immunity, Inflammation, and Cancer

(2010) Sergei I. Grivennikov et al.   CELL

Significance of Interleukin-6 Signaling in the Resistance of Pharyngeal Cancer to Irradiation and the Epidermal Growth Factor Receptor Inhibitor

(2010) Chih-Cheng Chen et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS